北美核成像市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

北美核成像市场按产品(按设备和放射性同位素)、按应用(SPECT 应用和 PET 应用)和地理划分。

市场快照

North America Nuclear Imaging Market |
Study Period: 2018 - 2026
Base Year: 2021
CAGR: 7 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

在预测期内,北美核成像市场预计将以 7% 的复合年增长率增长。推动市场增长的某些因素包括技术进步、增加各种疾病(如癌症和心血管疾病)的诊断应用、政府支持以及从独立模式向混合模式的转变。核成像在与心脏病学、神经学、骨科等相关的多种疾病的治疗中发挥着至关重要的作用。通过核成像进行诊断有助于检测癌症等多种疾病。根据美国癌症协会的估计,2018 年,美国约有 1,735,350 例新确诊癌症病例和 609,640 例死于癌症。

此外,成像领域的技术进步一直对从业者在如何最好地优化住院护理方面提出挑战。近年来,科学家、研究人员和技术人员已经能够将系统引入临床实践,其中结合了两种甚至两种以上的独立诊断成像模式。其中一些多模态成像系统包括 PET/CT、SPECT/CT、PET/MRI 和 PET/SPECT/CT。

此外,癌症和心脏病发病率的上升是市场的主要驱动力之一。核医学非常有能力治疗癌症和心脏病。有重要证据表明,使用核成像技术进行诊断对监测肿瘤的患者管理及其对药物的反应有更大的影响。

Scope of the report

Nuclear medicine imaging procedures are non-invasive, with the exception of intravenous injections, and are usually painless medical tests that help physicians diagnose and evaluate medical conditions. These imaging scans use radioactive materials called radiopharmaceuticals or radiotracers. These radiopharmaceuticals are used in diagnosis and therapeutics. They are small substances that contain a radioactive substance that is used in the treatment of cancer, cardiac and neurological disorders.

By Product
By Equipment
By Radioisotope
By Diagnostic Technology
SPECT Radioisotopes
Technetium-99m (TC-99m)
Thallium-201 (TI-201)
Gallium (Ga-67)
Iodine (I-123)
Other SPECT Radioisotopes
PET Radioisotopes
Fluorine-18 (F-18)
Rubidium-82 (RB-82)
Other PET Radioisotopes
By Application
SPECT Applications
Cardiology
Neurology
Thyroid
Other SPECT Applications
PET Applications
Oncology
Cardiology
Neurology
Other PET Applications
Geography
North America
United States
Canada
Mexico

Report scope can be customized per your requirements. Click here.

主要市场趋势

肿瘤学有望在 PET 应用中占据最高市场份额

在过去的二十年中,各种癌症的患病率显着上升。根据淋巴瘤研究基金会的统计,每年有超过 10 万人被诊断出患有淋巴瘤,美国有近百万人患有或正在缓解淋巴瘤。它是儿童中第三常见的癌症。

FDG-PET/CT 在分期几种类型的淋巴瘤或检测几种实体癌(如乳腺癌、肺癌和结肠癌)中的肿瘤播散方面比对比增强 CT 扫描更敏感。

在肿瘤学领域,PET(正电子发射断层扫描)使用 FDG(18Fluorine-2-fluoro-2-Deoxy-d-glucose)作为放射性药物,因为与正常细胞相比,它表明恶性细胞的新陈代谢增加. 此外,图像生成领域的技术不断进步。使用 PET 扫描作为生物标志物的复杂软件的引入促进了计算新预后标志物的新方法,例如代谢肿瘤体积 (MTV) 和肿瘤糖酵解总量 (TLG)。18F-氟脱氧葡萄糖(18F-FDG)具有高灵敏度,但不是肿瘤特异性的。该技术可用于肺癌、淋巴瘤、头颈部肿瘤、乳腺癌、食道癌、结直肠癌和泌尿道肿瘤的成像。因此,

Key trend Nuclear imaging_NA.png

竞争格局

北美核成像市场竞争分散,由几个主要参与者组成。就市场份额而言,目前很少有主要参与者占据市场主导地位。目前主导市场的一些公司是 Bracco Imaging SpA、Cardinal Health Inc.、GE Healthcare、Koninklijke Philips NV、Siemens Healthineers、Curium、CMR NAVISCAN (GAMMA MEDICA INC.)、Nordion (Canada) Inc.、NTP Radioisotopes SOC,佳能医疗系统公司

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rise in Prevalence of Cancer and Cardiac Disorders

      2. 4.2.2 Increase in Technological Advancements

      3. 4.2.3 Growth in Applications of Nuclear Medicine and Imaging

    3. 4.3 Market Restraints

      1. 4.3.1 Regulatory Issues

      2. 4.3.2 Lack of Reimbursement

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product

      1. 5.1.1 By Equipment

      2. 5.1.2 By Radioisotope

        1. 5.1.2.1 By Diagnostic Technology

          1. 5.1.2.1.1 SPECT Radioisotopes

            1. 5.1.2.1.1.1 Technetium-99m (TC-99m)

            2. 5.1.2.1.1.2 Thallium-201 (TI-201)

            3. 5.1.2.1.1.3 Gallium (Ga-67)

            4. 5.1.2.1.1.4 Iodine (I-123)

            5. 5.1.2.1.1.5 Other SPECT Radioisotopes

          2. 5.1.2.1.2 PET Radioisotopes

            1. 5.1.2.1.2.1 Fluorine-18 (F-18)

            2. 5.1.2.1.2.2 Rubidium-82 (RB-82)

            3. 5.1.2.1.2.3 Other PET Radioisotopes

    2. 5.2 By Application

      1. 5.2.1 SPECT Applications

        1. 5.2.1.1 Cardiology

        2. 5.2.1.2 Neurology

        3. 5.2.1.3 Thyroid

        4. 5.2.1.4 Other SPECT Applications

      2. 5.2.2 PET Applications

        1. 5.2.2.1 Oncology

        2. 5.2.2.2 Cardiology

        3. 5.2.2.3 Neurology

        4. 5.2.2.4 Other PET Applications

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Bracco Imaging SpA

      2. 6.1.2 Cardinal Health Inc.

      3. 6.1.3 GE Healthcare

      4. 6.1.4 Koninklijke Philips NV

      5. 6.1.5 Siemens Healthineers

      6. 6.1.6 Curium

      7. 6.1.7 CMR NAVISCAN (GAMMA MEDICA INC.)

      8. 6.1.8 Nordion (Canada) Inc.

      9. 6.1.9 NTP Radioisotopes SOC

      10. 6.1.10 Canon Medical Systems Corporation

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The North America Nuclear Imaging Market market is studied from 2018 - 2026.

The North America Nuclear Imaging Market is growing at a CAGR of 7% over the next 5 years.

Bracco Imaging SpA, Cardinal Health Inc., GE Healthcare, Koninklijke Philips NV, Siemens Healthineers are the major companies operating in North America Nuclear Imaging Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!